Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.0076
+0.0012 (18.75%)
Mar 9, 2026, 5:01 PM CET
STO:LPGO Market Cap
STO:LPGO has a market cap or net worth of 4.61 million as of March 9, 2026. Its market cap has decreased by -78.04% in one year.
Market Cap
4.61M
Enterprise Value
-11.99M
Revenue
1.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 1, 2021, STO:LPGO's market cap has decreased from 97.91M to 4.61M, a decrease of -95.30%. That is a compound annual growth rate of -45.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.61M | -11.63% |
| Dec 30, 2025 | 5.21M | -69.56% |
| Dec 30, 2024 | 17.12M | -68.59% |
| Dec 29, 2023 | 54.49M | 240.70% |
| Dec 30, 2022 | 15.99M | -74.72% |
| Dec 30, 2021 | 63.26M | -35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stayble Therapeutics AB | 10.94M |
| NanoEcho AB | 12.22M |
| Fluicell AB | 14.84M |
| Novakand Pharma AB | 15.08M |
| ExpreS2ion Biotech Holding AB | 18.07M |
| Aptahem AB | 19.50M |
| Guard Therapeutics International AB | 31.06M |
| 2cureX AB | 33.64M |